Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorKutlay, Özden
dc.contributor.authorYalim, Zafer
dc.contributor.authorKeskin Aktan, Arzu
dc.contributor.authorKoca, Tülay
dc.date.accessioned2023-11-06T12:32:36Z
dc.date.available2023-11-06T12:32:36Z
dc.date.issued2022en_US
dc.identifier.citationKutlay, Ö., Yalım, Z., Aktan, A. K., & Koca, T. (2022). Association Between Carotid Artery Disease and ABO Blood Group. Erciyes Medical Journal/Erciyes Tip Dergisi, 44(3).en_US
dc.identifier.issn2149-2549
dc.identifier.urihttps://dx.doi.org/10.14744/etd.2021.70670
dc.identifier.urihttps://hdl.handle.net/20.500.12933/1697
dc.description.abstractObjective: Carotid artery disease (CAD) is a type of cardiovascular disease typically caused by the formation of atherosclerotic plaques in the carotid arteries. Diabetes mellitus, hereditary features, hyperlipidemia, and hypertension are significant risk factors for CAD. There is strong evidence of a relationship between these major risk factors and the ABO blood groups. The aim of this retrospective study was to examine a potential relationship between the ABO blood groups and CAD. Materials and Methods: The study group comprised 230 consecutive patients diagnosed with CAD using carotid angiography between January 2012 and November 2019 and 136 consecutive subjects without CAD as controls. The data analyzed were collected from patient files: details of demographic characteristics, lipid profiles (total cholesterol, low-density lipoprotein, high-density lipoprotein, very-low-density lipoprotein, and triglyceride levels), and hematological indices (leukocyte, platelet, hemoglobin, mean platelet volume, neutrophil, lymphocyte, monocyte values). Results: Chi-squared test analysis indicated that there was a statistically significant difference between the distribution of the blood groups in the patient and control groups (p=0.017). Multiple logistic regression analysis demonstrated that the risk of developing CAD was 1.92 times higher in the non-O blood groups than in the O blood group (p=0.032). Conclusion: A non-O blood group may be another risk factor for CAD. However, the blood group must be evaluated alongside established risk factors to fully understand the risk of developing CAD.en_US
dc.language.isoengen_US
dc.publisherAli Cangülen_US
dc.relation.isversionof10.14744/etd.2021.70670en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleAssociation between carotid artery disease and ABO blood groupen_US
dc.typearticleen_US
dc.authorid0000-0001-5509-6650en_US
dc.departmentAFSÜen_US
dc.contributor.institutionauthorKutlay, Özden
dc.contributor.institutionauthorYalim, Zafer
dc.contributor.institutionauthorKeskin Aktan, Arzu
dc.contributor.institutionauthorKoca, Tülay
dc.identifier.volume44en_US
dc.identifier.issue3en_US
dc.identifier.startpage293en_US
dc.identifier.endpage298en_US
dc.relation.journalErciyes Medical Journalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster